On April 4, 2022, Jeffery Baxter notified ChromaDex Corporation (the Company") of his intention to resign from the board of directors of the Company (the Board") and as a member of the Audit Committee and Nominating and Corporate Governance Committee of the Board. The effective date of Mr. Baxter's resignation is April 4, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.55 USD | -4.49% | -4.80% | +80.42% |
06-25 | ChromaDex Chief Financial Officer Brianna Gerber to Resign | MT |
06-24 | ChromaDex Says Nicotinamide Riboside Shows 'Promising Effects' in Peripheral Artery Disease Trial | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+80.42% | 202M | |
+21.65% | 46.93B | |
+37.63% | 39.08B | |
-8.36% | 38.48B | |
+29.23% | 31.01B | |
-13.75% | 26.14B | |
+11.16% | 25.88B | |
+36.31% | 12.53B | |
-6.47% | 11.36B | |
-12.38% | 10.65B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- Jeffery Baxter Notifies His Intention to Resign from Board of ChromaDex